New stent for heart patients with high bleeding risk
Part of Heart & circulation clinical trials.
This study tests a new type of stent (a small mesh tube that opens a blocked heart artery) designed to reduce bleeding risks in people who are more likely to bleed. If you are having a coronary angioplasty and are at high risk of bleeding, this might be a good option to discuss with your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to be scheduled for a coronary angioplasty (a procedure to open a blocked heart artery) and receive a special stent called HT-supreme.
- You must be considered at high risk of bleeding (as judged by your doctor).
- You need to be affiliated with a social security health system (in France).
- You should not object to participating in research.
- You must not be allergic to aspirin, clopidogrel, or the contrast dye used during the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
This trial tests a new type of stent (BioFreedom Ultra) compared to a standard one (BioFreedom) in people who have a high risk of bleeding. Both stents release medicine to keep arteries open, and the study checks if the newer stent works better with a shorter course of blood thinners.
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Hear when a new Cardiology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.